MLKN · MillerKnoll, Inc.

Current Thesis

MillerKnoll's recovery re-rating has broken its published price condition, and the 2026-09-22 results will test whether orders support a replacement thesis. The measured change is decisive: the adjusted close of $20.66 on Friday, 2026-09-18, breached the $22 weekly-close invalidation published on 2026-09-06. The interpretation follows from that breach: the narrative is dead as an August-breakout thesis, dated by the 2026-09-18 weekly close.

The underlying operating proposition remains identifiable: stronger furniture sales and earnings eventually accompanied by recovering demand. However, the 2026-06-24 results showed organic sales growth alongside declining organic orders and backlog. The company has confirmed results before market open on 2026-09-22; that report can establish new evidence, but cannot reverse the historical price invalidation. Company scheduling announcement, 2026-08-25.

Bullish and bearish views on MillerKnoll, Inc.

The model's bull view on MillerKnoll, Inc. (MLKN), in brief: Revenue and earnings execution. MillerKnoll's 2026-06-24 release reported fourth-quarter fiscal 2026 sales of $1.004 billion, up 4.4% reported and 3.7% organically. Adjusted earnings per share of $0.55 exceeded the company's $0.51–$0.53 guidance range; this supports execution in… The bear view: Orders lagged recognized revenue. The 2026-06-24 release reported fourth-quarter orders of $972 million, down 6.3% reported and 6.9% organically, while backlog was $679 million, down 10.8% year over year. Those measurements leave the demand component of the recovery unconfirmed.… Both cases follow in full.

Bull Case

• Revenue and earnings execution. MillerKnoll's 2026-06-24 release reported fourth-quarter fiscal 2026 sales of $1.004 billion, up 4.4% reported and 3.7% organically. Adjusted earnings per share of $0.55 exceeded the company's $0.51–$0.53 guidance range; this supports execution in that quarter, without establishing an order recovery.
• Management supplied measurable hurdles. Guidance issued on 2026-06-24 put fiscal 2027 sales at $3.93–$4.13 billion and adjusted earnings per share at $1.85–$2.15. A replacement recovery case would require improving orders alongside delivery against that outlook; a guidance reduction would contradict it.

Bear Case

• Orders lagged recognized revenue. The 2026-06-24 release reported fourth-quarter orders of $972 million, down 6.3% reported and 6.9% organically, while backlog was $679 million, down 10.8% year over year. Those measurements leave the demand component of the recovery unconfirmed.
• The published condition failed. The 2026-09-18 adjusted weekly close of $20.66 was below the $22 threshold specified in the 2026-09-06 dossier. Retaining that original condition records a failed breakout thesis rather than moving the threshold after the decline.

Setup & Price Structure

The supplied adjusted series places the 2026-09-18 close at $20.66, 14.9% below its $24.29 trailing-year high, despite a three-month price increase of 32.1%. Its 14-period relative strength index (RSI) was 28.1 on that date. These are price and momentum observations; they do not establish a reversal or a new support shelf.

The relevant research level remains the previously published $22 threshold. A weekly close back above $22 would satisfy the price component of reassessment, but a subsequent weekly close below $22 would defeat that recovery condition. No moving-average value or trading-volume series is supplied, so neither distance from a rising average nor expanding participation can be established.

A dividend-income headline dated 2026-09-15 supplies an observable example of retail-facing attention ahead of earnings. That isolated item is too small a sample to support a crowding claim. The 2026-08-04 and 2026-08-05 Form 144 notices cited in the previous dossier concern proposed affiliate sales; without corresponding execution evidence, they do not establish completed selling.

Catalyst Calendar (next 30 days)

• 2026-09-22 — First-quarter fiscal 2027 results. Results are scheduled before market open, followed by an 8:30 a.m. Eastern conference call. The operating comparisons are the 2026-06-24 guidance of $928–$968 million revenue and $0.33–$0.39 adjusted earnings per share, together with the reported $679 million backlog and declining organic orders. Company announcement, 2026-08-25.
• 2026-10-12 — Annual shareholder meeting. The proxy filed on 2026-08-28 schedules the virtual meeting for 10:30 a.m. Eastern and includes a vote on the 2026 Long-Term Incentive Plan. The vote resolves an equity-compensation authorization; approval alone would not establish actual issuance. MillerKnoll proxy statement.

What Would Change Our Mind

Loss of the published breakout condition has already settled the original price test: a weekly close below $22 occurred on 2026-09-18 at $20.66. The forthcoming earnings report cannot make that earlier thesis successful retroactively.

A replacement recovery interpretation would require a weekly close above $22 alongside positive year-over-year organic order growth and backlog above the $679 million reported on 2026-06-24. Continued organic order contraction with backlog below that amount in the 2026-09-22 results would reject the proposed demand recovery; a subsequent weekly close below $22 would reject the price recovery. These are conditions for reassessment, not outcomes established by the current evidence.

Correlation Notes

The 2026-09-18 observation set supplies MillerKnoll's three-month price increase of 32.1%, but no matched peer, housing-equity or interest-rate return series. It therefore cannot establish that a group move caused the advance or the subsequent structural failure. The research remains a single-company case tied to the 2026-09-22 order and guidance disclosures; the industry tags describe exposure, not measured correlation.